This CPB is revised to state that TAVI is considered experimental and investigational for persons with ongoing sepsis, including endocarditis. This CPB has been revised to state that the following are considered experimental and investigational: (i) combination of transcatheter aortic valve implantation (TAVI) and left atrial appendage occlusion, and (ii) TAVI with pre-implantation balloon aortic valvuloplasty.